RetaMaps

Kathleen Wyne, M.D.

Kathleen Wyne, M.D. · 181 Taylor Ave. · Columbus, OH 43203

4.5· 11 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss
  • Endocrine / metabolic care

About this practice

Kathleen Wyne, M.D. is listed under weight-loss care, endocrine and aesthetics services in Columbus, Ohio, and the listing offers telehealth. The website attached to it is that of The Ohio State Wexner Medical Center. On Google the listing has a 4.5-star rating across 11 reviews dating back to 2018, 1 of them from the past year, and two reviews each mention the staff, a caring approach and scheduling.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsYes
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.5
Google rating · 11 reviews
1
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-01-03. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.5 across 11 Google reviews. Of the 8 reviews we analyzed, 6 (75%) are positive (4–5★) and 1 (13%) are negative (1–2★).

What patients like

  • Friendly, helpful staff2 reviews
  • Feeling listened to2 reviews

Common complaints

Very few complaints — only 1 negative review, with no recurring theme.

5★
6
4★
0
3★
1
2★
0
1★
1

Most recent Google reviews

Michael T.★★★★★2024-08-23

Dr. Wyne has a friendly, calming, competent demeanor. Her experience treating diabetics is evident. Alison in her Hilliard office has been extremely helpful on multiple occasions sorting out problems related to low supplies of prescriptions at the pharmacist.

Ellen B.★★★★★2024-07-01

Dr. Wyne, is one of very few doctors that I have that actually takes the time to make sure you understand everything. She also listens to your concerns. I would highly recommend her to any patient. Thanks Dr. Wyne Ellen

Kenya M.★★★★★2024-06-27

I think she’s good at what she does! I’m glad to know I’m in good hands!! Thanks for the extra effort Doctor Wyne!

Cassidy K.★★★★★2022-10-01

I have only had one appointment with Dr. Wyne so far, but the care I received at this office was awesome. As many Type 1's know, it can be very difficult to find adequate care. I've been Type 1 Diabetic for 13 years, and I have had my fair share of doctors who truly didn't know what to do with me, and I felt like I had to educate them. This was not my experience here. Everyone was kind, welcoming, and most importantly... thorough! I was able to meet with a PA, Dietitian, and Dr. Wyne all in one visit. What typically is an in-and-out visit was almost 3 hours long of great education and thorough medical history. I feel at this office I will be held accountable for staying diligent about my health, which is what everyone needs every once in a while with a disease this demanding! Very happy to have Dr. Wyne as my provider.

Aaron R.★★★★★2022-06-16

I have never had a Dr that is worse with follow up than Dr. Wyne. I'm still trying over a month after my visit to get her to actually send my prescriptions to the pharmacy. This isn't the first or only time this has happened. On top of that I have had an instance with her where she completely berated me for daring to contact her outside of a regularly scheduled appointment despite having lab values that were off the charts high and I wasn't sure if it was a medical emergency or not. I only tried to contact her in that instance because of the out of whack value and the fact she has never once followed up with me on labs like every other Dr does. The quality of care leaves much to be desired.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Kathleen Wyne, M.D.

Nearby providers in Columbus

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs